Fundraising Fox

Iain Dukes

Investor

Venture Partner at OrbiMed · Board director at Theseus Pharmaceuticals · Board director at Angiex · Board director at Ikena Oncology, Inc.

Philadelphia, Pennsylvania

Writes $1M – $75M checks · typically $4M

Find your path to Iain

789 people in our graph share verified history with Iain — schools, employers, funds. One of them is your warm intro.

Dominic JacquessonunlockedIain: together at University of Oxford (1989)
Iain: together at University of Oxford
×2Iain: together at GlaxoSmithKline
×3Iain: together at University of Leeds

About

Iain Dukes is a Venture Partner at Orbimed and CEO of Viriom Inc, serving on the executive teams or boards of nine companies across the USA, France, and the UK. His career includes roles as Senior Vice President of Business Development & Licensing at Merck, where he managed licensing deals for Merck Research Laboratories, as well as Vice President of External Research and Development at Amgen, President and CEO of Essentialis Therapeutics, and Vice President of Scientific and Technology Licensing at GlaxoSmithKline. He holds a BSc in Pharmacology from the University of Bath, an MSc in Cardiovascular Studies from the University of Leeds, a DPhil in Physiology and Pharmacology from the University of Oxford, and an MA in Jurisprudence and Law from the University of Oxford.

Board director at Theseus Pharmaceuticals

Intro paths

→

In turn, Iain can intro founders to Theseus Pharmaceuticals's investors below.

Theseus Pharmaceuticals's investors · 4

Foresite CapitalWest Hollywood · since 2018Longitude CapitalMenlo Park · $10M – $30M checks · since 2021Nextech InvestZurich · $648K – $3.2M checks · since 2021OrbiMedNew York · $1M – $75M checks · since 2018

Co-founders at Theseus Pharmaceuticals

WC
William C. ShakespeareDirector

Board director at Angiex

Intro paths

→

In turn, Iain can intro founders to Angiex's investors below.

Angiex's investors · 3

Green Meadow VenturesWest Hollywood · $500K – $3M checks · since 2017K5 GlobalSan Francisco · $1M – $3M checks · since 2017OrbiMedNew York · $1M – $75M checks · since 2025

Co-founders at Angiex

PJPaul Jaminet
Paul JaminetExecutive Officer, Director

Board director at Ikena Oncology, Inc.

Intro paths

→

In turn, Iain can intro founders to Ikena Oncology, Inc.'s investors below.

Ikena Oncology, Inc.'s investors · 6

Atlas VentureCambridge · $500K – $1M checks · since 2025Biotechnology Value FundSan FranciscoForesite CapitalWest HollywoodOmega FundsBoston · since 2025OrbiMedNew York · $1M – $75M checks · since 2025RTW Investments L.P.New York

Experience

  1. Viriom IncCEOcurrent2019 — presentSan Diego, CA
  2. Theseus PharmaceuticalsCEOcurrent2018 — presentCambridge, MA
  3. ENYO PharmaBoard Membercurrent2018 — presentLyon, France
  4. KaNDY Therapeutics, Ltd.Chairman of the Boardcurrent2017 — presentStevenage, UK
  5. Kartos TherapeuticsPresidentcurrent2017 — present
  6. NeRRE Therapeutics, Ltd.Board Membercurrent2017 — presentStevenage, England, United Kingdom
  7. ReViral, Ltd.Board Membercurrent2016 — presentStevenage, England, United Kingdom
  8. Iovance Biotherapeutics, Inc.Chairman of the Boardcurrent2016 — presentSan Carlos, CA
  9. Kyn Therapeutics, Inc.Board Membercurrent2016 — presentBoston, MA
  10. OrbiMedVenture Partnercurrent2016 — presentNew York, NY
  11. MerckSVP Licensing & External Science2013 — 2016Upper Gwynedd, Pa
  12. AmgenVP External R&D2010 — 2013
  13. Biotech ConsultingPresident2009 — 2010Greater Philadelphia
  14. Essentialis TherapeuticsPresident & CEO2007 — 2009San Diego County, California, United States
  15. GlaxoSmithKlineVP Scientific and Technology Licensing2000 — 2007Research Triangle Park, NC

Skills & more

Biotechnology6R&D11FDA4Pharmaceutical Industry10Drug Discovery6Licensing11Clinical Development6Lifesciences3Strategy4Drug Development11Biopharmaceuticals13Technology Transfer3
+4 moreBusiness DevelopmentOncologyLife SciencesCommercialization

From Iain's professional profile.

Deals · 2

AngiexBoard seat

via OrbiMed · filed Sep 2025 · $28.4M raise

Ikena Oncology, Inc.Board seat

via OrbiMed · filed Jul 2025 · $75M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at OrbiMed

Aldo Brambilla
Associate at Silver Lake Partners
Alexander M. Cooper
Investor at OrbiMed
Anat Naschitz
Executive Officer at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Ava Poole
Investor at Insight Partners

Frequently asked questions

Who is Iain Dukes?
Iain Dukes is a Venture Partner at Orbimed and CEO of Viriom Inc, serving on the executive teams or boards of nine companies across the USA, France, and the UK. His career includes roles as Senior Vice President of Business Development & Licensing at Merck, where he managed licensing deals for Merck Research Laboratories, as well as Vice President of External Research and Development at Amgen, President and CEO of Essentialis Therapeutics, and Vice President of Scientific and Technology Licensing at GlaxoSmithKline. He holds a BSc in Pharmacology from the University of Bath, an MSc in Cardiovascular Studies from the University of Leeds, a DPhil in Physiology and Pharmacology from the University of Oxford, and an MA in Jurisprudence and Law from the University of Oxford.
Where does Iain Dukes work?
Iain Dukes is Venture Partner at OrbiMed and Board director at Theseus Pharmaceuticals and Board director at Angiex and Board director at Ikena Oncology, Inc..
What check size does Iain Dukes write?
Iain Dukes typically writes checks of $1M – $75M.
What boards does Iain Dukes sit on?
Iain Dukes holds tracked board seats at Angiex, Ikena Oncology, Inc..
Where did Iain Dukes go to school?
Iain Dukes studied at University of Oxford (MA, Jurisprudence (Law)); University of Oxford (DPhil, Physiology/Pharmacology); University of Leeds (MSc, Cardiovascular Studies).

Founder mafias

University of Oxford mafia623

Also came through, then founded or led a company.

Reid HoffmanM.St.Founded LinkedIn +2Gabriel PereyraDropped outFounded HarveyBrent HobermanMaster of Arts - MAFounded Founders Pledge +4William GuttmanM.PhilFounded CurvePoint +3Tom BlomfieldBA JurisprudenceFounded Starling Bank +2Kevin HartzMstFounded Eventbrite +2

+ 616 more

University of Bath mafia63

Also came through, then founded or led a company.

Paul HetheringtonIntegrated Mechanical & Electrical Engineering (MEng)Founded Hlabs +1George Kalligeros(MEng) Masters in Mechanical EngineeringFounded Aseon +1Pedro GomesHigher National Certificate (HNC)Founded Reown +1Dominic LewisInternational Business Management + EconomicsFounded Tray +1Jack RogersBA Hons Modern Languages with European Studies (Russian and French)Founded Picknic Media +1Arne GeschkeMaster of Industrial MathematicsFounded Fair Supply +1

+ 56 more

University of Leeds mafia50

Also came through, then founded or led a company.

Jack AngelaBachelor of Arts (B.A.)Founded Meanderx +1John FordBSc (1st Class)Founded Metrion Biosciences +1Richard GodwinMBAFounded AlumaPowerSir Steve JacksonBSc HonsFounded Mission TherapeuticsTony KouzaridesFounded Storm TherapeuticsSteve JacksonBSc HonsFounded Mission Therapeutics

+ 43 more

Amgen mafia25

Also came through, then founded or led a company.

Parker ConradProduct ManagerFounded Zenefits +1Howard ChangSVP Global Research & Chief Scientific OfficerFounded Accent Therapeutics +3Ferry TamtoroDirector, Digital Accelerator Labs, Digital Health ProductsFounded Revisto +1Zhengbin (Bing) YaoResearch ScientistFounded Arrivent +1Seth LieblichBusiness DevelopmentFounded ProtomerJames LiVice President and General Manager, Greater ChinaFounded JW Therapeutics

+ 18 more

OrbiMed mafia10

Also came through, then founded or led a company.

Peter ThompsonGeneral PartnerFounded Cleave Biosciences +4Peter Thompson, M.D.General PartnerFounded Cleave Biosciences +4Matthew R. PattersonEntrepreneur-In-ResidenceFounded Audentes Therapeutics +2Sheila Gujrathi, MDVenture AdvisorFounded Prana Therapies +1Tadd WesselPartnerFounded PetrichorSteven YeciesVenture PartnerFounded Javelin Oncology

+ 3 more

Same school

Also attended University of Oxford1,553

Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures

+ 1,547 more

Also attended University of Leeds189

Joseph StolermanInvestor at Index VenturesLaura CliffordTalent Director at NorthzoneJason MorrisVice President, Investor Relations at Sapphire VenturesIan MilbournGeneral Partner & COO at Notion CapitalJohn MesrieOperating Partner at Inreach VenturesPhil TomkinsonFinance & Portfolio Associate at Giant Ventures Global Llp

+ 183 more

Also attended University of Bath194

Catherine BergersenSenior Executive Assistant at Mayfair Equity PartnersJohanInvestor at InvestinorMaddie CoughlinInvestor at DN CapitalBen PalmerInvestment Professional at OxxJuliette PetitChief of Staff at Keen Venture PartnersSarah HollyheadDirector at Marlin Equity Partners

+ 188 more

Shared employers

Also worked at ENYO Pharma3

Aneta SottilPartner at Andera PartnersAnnette ClancyPharma M&A Strategy at Jeito CapitalBenoît de ChasseyFounder, Head of Drug Discovery Platform at Enyo Pharma

Also worked at Kartos Therapeutics2

Maria FardisVenture Partner at Frazier Life SciencesRoger UlrichSenior Advisor at Frazier Life Sciences

Also worked at Iovance Biotherapeutics, Inc.1

Maria FardisVenture Partner at Frazier Life Sciences

Also worked at Merck153

Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesUri LopatinInvestor at Khosla Ventures

+ 147 more